2017
DOI: 10.1016/j.bpg.2017.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
128
1
3

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 153 publications
(147 citation statements)
references
References 99 publications
4
128
1
3
Order By: Relevance
“…Genetic variation, environmental factors and genome variability are some of the multiple factors that influence chronic HBV infection . There exist remarkable differences in the geographical distribution of HBV genotypes …”
Section: Introductionmentioning
confidence: 99%
“…Genetic variation, environmental factors and genome variability are some of the multiple factors that influence chronic HBV infection . There exist remarkable differences in the geographical distribution of HBV genotypes …”
Section: Introductionmentioning
confidence: 99%
“…Ten genotypes of HBV have been identified labeled A through J . The prevalence of HBV genotypes varies geographically.…”
Section: Selected Diagnostic Tests Used In Management Of Chronic Hepamentioning
confidence: 99%
“…HBV genotypes A through H have been found in the United States, with genotypes A, B, and C being most prevalent . HBV genotypes may play an important role in the progression of HBV‐related liver disease as well as response to interferon (IFN) therapy . Genotype A (vs. B‐D) is associated with significantly higher rates of HBeAg and HBsAg loss with IFN therapy .…”
Section: Selected Diagnostic Tests Used In Management Of Chronic Hepamentioning
confidence: 99%
See 1 more Smart Citation
“…Another point to consider is the fact that the current study was performed only with one HBV isolate/genotype (genotype D). The HBV genotype is known to affect viral pathogenesis, disease progression, and response to treatment with interferon-alpha (Lin and Kao, 2017). As chronic HBV infection is not a homogenous disease with singular clinical presentation, studies with varying degrees of infection rates and/or different HBV genotypes are warranted to inform about the changes in ADME profile of a HBV compound in healthy and diseased states.…”
Section: Future Applications -Diseased Statementioning
confidence: 99%